API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fiercebiotech.com/biotech/vistagen-fails-phase-2-depression-trial-sparking-stock-rout
https://endpts.com/microcap-biotech-vistagen-turned-to-pennystock-after-phii-results-show-its-depression-drug-doesnt-work-solo/
https://seekingalpha.com/article/4158084-vistagen-nanocap-cns-drug-chasing-ketamine-fame
http://www.marketwired.com/press-release/vistagen-therapeutics-initiates-phase-2-study-av-101-major-depressive-disorder-nasdaq-vtgn-2246564.htm
https://seekingalpha.com/news/3326447-investors-unimpressed-vistagen-update-avminus-101-shares-16-percent
https://www.drugtargetreview.com/article/21644/ketamine-depression/